The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production - PubMed (original) (raw)
The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production
C McMenamin et al. J Exp Med. 1993.
Abstract
The immunological basis for atopy is currently ascribed to an inherent bias in the CD4+ T cell response to nonreplicating antigens presented at mucosal surfaces, resulting in dominance of the T helper 2 (Th2) interleukin 4 (IL-4)-producing phenotype, which favors IgE production. In contrast, the "normal" response to such antigens involves a predominance of interferon gamma (IFN-gamma)-producing Th1 clones. This difference has been suggested to be the result of active selection in atopics for Th2 (and hence against Th1) clones at the time of initial antigen presentation. In the study below, we demonstrate that the natural immune response to inhaled protein antigens, particularly in animals expressing the low immunoglobulin E (IgE) responder phenotype, includes a major histocompatibility complex (MHC) class I-restricted CD8+ T cell component, the appearance of which is associated with active suppression of IgE antibody production. Thus, continued exposure of rats to aerosolized ovalbumin (OVA) antigen elicits a transient IgE response, that is terminated by the onset of a state of apparent "tolerance" to further challenge, and this tolerant state is transferable to naive animals with CD8+ T cells. Kinetic studies on in vitro T cell reactivity in these aerosol-exposed rats demonstrated biphasic CD4+ Th2 responses which terminated, together with IgE antibody production, and coincident with the appearance of MHC class I-restricted OVA-specific IFN-gamma-producing CD8+ T cells. However, the latter were not autonomous in vitro and required a source of exogenous IL-2 for initial activation, which in CD(8+)-enriched splenocyte cultures could be provided by small numbers of contaminating OVA-specific CD4+ T cells. This represents the first formal evidence for the induction of an MHC class I-restricted T cell response to natural mucosal exposure to an inert protein antigen, and is consistent with a growing literature demonstrating sensitization of MHC class I-restricted CD8+ T cells by deliberate immunization with soluble proteins. We suggest that crossregulation of MHC class II-restricted CD4+ T cells via cytokine signals generated in parallel CD8+ T cell responses represents a covert and potentially important selection pressure that can shape the nature of host responses to nonreplicating antigens presented at mucosal surfaces.
Similar articles
- Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
Pouniotis DS, Esparon S, Apostolopoulos V, Pietersz GA. Pouniotis DS, et al. Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8. Immunol Cell Biol. 2011. PMID: 21383765 - Generation of rat MHC class-I-restricted ovalbumin-specific IgE inhibitory CD8+ T cell clones.
MacAry PA, Holmes BJ, Kemeny DM. MacAry PA, et al. Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):279-80. doi: 10.1159/000237572. Int Arch Allergy Immunol. 1997. PMID: 9130548 - Immunoregulation of the allergic reaction in the respiratory tract.
Holt PG. Holt PG. Eur Respir J Suppl. 1996 Aug;22:85s-89s. Eur Respir J Suppl. 1996. PMID: 8871050 Review. - Cytokines involved in the generation of cytolytic effector T lymphocytes.
Plate JM, Lukaszewska TL, Bustamante G, Hayes RL. Plate JM, et al. Ann N Y Acad Sci. 1988;532:149-57. doi: 10.1111/j.1749-6632.1988.tb36334.x. Ann N Y Acad Sci. 1988. PMID: 2460006 Review.
Cited by
- Gesundheit! Patrick Holt smothers allergies and asthma.
Maxmen A. Maxmen A. J Exp Med. 2009 Dec 21;206(13):2858-9. doi: 10.1084/jem.20613pi. J Exp Med. 2009. PMID: 20026665 Free PMC article. - Inhibitory effects of endogenous and exogenous interferon-gamma on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats.
Huang TJ, MacAry PA, Wilke T, Kemeny DM, Chung KF. Huang TJ, et al. Immunology. 1999 Oct;98(2):280-8. doi: 10.1046/j.1365-2567.1999.00870.x. Immunology. 1999. PMID: 10540228 Free PMC article. - Building better mouse models of asthma.
Lloyd CM. Lloyd CM. Curr Allergy Asthma Rep. 2007 Jun;7(3):231-6. doi: 10.1007/s11882-007-0077-0. Curr Allergy Asthma Rep. 2007. PMID: 17448336 Free PMC article. Review. - Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4.
Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Herrick CA, et al. J Clin Invest. 2000 Mar;105(6):765-75. doi: 10.1172/JCI8624. J Clin Invest. 2000. PMID: 10727445 Free PMC article. - Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
Kjerrulf M, Grdic D, Ekman L, Schön K, Vajdy M, Lycke NY. Kjerrulf M, et al. Immunology. 1997 Sep;92(1):60-8. doi: 10.1046/j.1365-2567.1997.00312.x. Immunology. 1997. PMID: 9370925 Free PMC article.
References
- Immunology. 1981 Mar;42(3):409-17 - PubMed
- J Exp Med. 1991 Oct 1;174(4):791-8 - PubMed
- Biochem J. 1982 Apr 1;203(1):293-8 - PubMed
- Immunol Rev. 1983;74:57-82 - PubMed
- Immunology. 1983 Dec;50(4):625-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials